Cardiac and metabolic effects of dibutyryl cyclic AMP in the intact dog heart and the isolated perfused rat heart.
D000227:Adenine Nucleotides / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003994:Bucladesine / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D000242:Cyclic AMP / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D007700:Kinetics; D008931:Mitochondria, Muscle / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects
D000227:Adenine Nucleotides; D001786:Blood Glucose; D010725:Phosphocreatine; D003994:Bucladesine; D011433:Propranolol; D000242:Cyclic AMP; D000251:Adenosine Triphosphatases; D002118:Calcium; D004837:Epinephrine